Dementia expert says evidence behind Biogen Alzheimer's drug 'wasn’t sufficient' for FDA approval

cnbc2021-06-08

Dementia expert Dr. Jason Karlawish told CNBC he's skeptical of theFood and Drug Administration's approvalofBiogen's Alzheimer's disease drug, Aduhelm, saying "the evidence to approve the drug wasn't ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

CleavonFx
2021-06-10
CleavonFx
.
- CleavonFx:
  .
Annalz
2021-06-08
Annalz
Haha
bunny9078
2021-06-08
bunny9078
Ooo
- TCRaN:
  ok
Pigmonkey
2021-06-08
Pigmonkey
Comment pls
- szueyann:
  ok. done
- XNOP593:
  Response back
JamesPang
2021-06-08
JamesPang
Like and comment
- ShenSiang:
  Ok
- Pigmonkey:
  Ok
szueyann
2021-06-08
szueyann
Please like and comment. Thanks
- szueyann:
  thanks
- Monies:
  Ok

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1113342569?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-06-08 09:07","share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","id":"1113342569","market":"us","top_or_hot":-1,"title":"Dementia expert says evidence behind Biogen Alzheimer's drug 'wasn’t sufficient' for FDA approval","media":"cnbc","content":"<div>\n<p>Dementia expert Dr. Jason Karlawish told CNBC he's skeptical of theFood and Drug Administration's approvalofBiogen's Alzheimer's disease drug, Aduhelm, saying \"the evidence to approve the drug wasn't ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/07/biogen-alzheimers-drug-dementia-expert-says-evidence-wasnt-sufficient-for-approval.html\">Source Link</a>\n\n</div>\n","source":"cnbc_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dementia expert says evidence behind Biogen Alzheimer's drug 'wasn’t sufficient' for FDA approval</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDementia expert says evidence behind Biogen Alzheimer's drug 'wasn’t sufficient' for FDA approval\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-08 09:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/07/biogen-alzheimers-drug-dementia-expert-says-evidence-wasnt-sufficient-for-approval.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Dementia expert Dr. Jason Karlawish told CNBC he's skeptical of theFood and Drug Administration's approvalofBiogen's Alzheimer's disease drug, Aduhelm, saying \"the evidence to approve the drug wasn't ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/07/biogen-alzheimers-drug-dementia-expert-says-evidence-wasnt-sufficient-for-approval.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BIIB","symbol_name":"渤健公司","start_time":0,"source_url":"https://www.cnbc.com/2021/06/07/biogen-alzheimers-drug-dementia-expert-says-evidence-wasnt-sufficient-for-approval.html","article_id":"1113342569","we_media_id":null,"thumbnails":[],"rights":{"source":"cnbc_highlight","url":"https://www.cnbc.com/2021/06/07/biogen-alzheimers-drug-dementia-expert-says-evidence-wasnt-sufficient-for-approval.html","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.ArticleHeader-headline{#titleStyle#}a{#lv2TextColor#}.ArticleHeader-time, .Author-authorNameAndSocial a{#sourceStyle#;}","selectors":".PageBuilder-pageWrapper","filters":".ArticleHeader-eyebrow, .RelatedTags-relatedTags","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=1113342569","pubTimestamp":1623114456,"sourceInfo":{"source_id":"cnbc_highlight","name":"CNBC"},"weMediaInfo":null,"summary":"Dementia expert Dr. Jason Karlawish told CNBC he's skeptical of theFood and Drug Administration's ap","collect":0,"end_time":0,"defaultTopTitle":"cnbc.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BIIB":"渤健公司"},"translate_title":"一位痴呆症专家说，生化基因阿尔茨海默氏症药物背后的证据不足以让FDA批准","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BIIB":0.9},"content_text":"Dementia expert Dr. Jason Karlawish told CNBC he's skeptical of theFood and Drug Administration's approvalofBiogen's Alzheimer's disease drug, Aduhelm, saying \"the evidence to approve the drug wasn't sufficient.\"\"Another study is needed to establish whether this drug, in fact, is effective. Unfortunately, the FDA approved the drug for marketing, although they also do want another study,\" the co-director of the Penn Memory Center at the University of Pennsylvania said on Monday following the agency's formal OK.The FDA's approval marks thefirst new treatment for Alzheimer'sin nearly two decades. Alzheimer's is a progressive neurodegenerative disorder that slowly destroys memory and thinking skills. More than 6 million Americans live with the disease, according toestimates by the Alzheimer's Association.Karlawish told\"The News with Shepard Smith\"that there are a lot of promising Alzheimer's drugs in the pipeline.\"I'm optimistic about the coming future here, so I have hope. I just think this is not the drug upon which to pin our hopes,\" he said. \"Desperation should drive funding for Alzheimer's research, it should not drive the interpretation of scientific evidence.\"Clinical trials found some patients who got the approved dose of Aduhelm experienced painful brain swelling.\"What you're asking someone to do, is to take a chance at uncertain benefit, but known risk,\" Karlawish said of prescribing the drug to patients.The FDA said it will continue to monitor the drug as it reaches the U.S. market. The agency granted approval on the condition that Biogen conduct another clinical trial.Karlawish told host Shepard Smith that Biogen will face a challenge in \"how to do that study when the drug is also available for clinical prescribing.\"Representatives for Biogen and for the FDA did not immediately return requests for comment on Karlawish's statements.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":183913758,"gmtCreate":1623299787774,"gmtModify":1704200394530,"author":{"id":"3577625682381834","authorId":"3577625682381834","name":"CleavonFx","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3577625682381834","authorIdStr":"3577625682381834"},"htmlText":".","listText":".","text":".","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/183913758","repostId":1113342569,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7232239,"gmtCreate":1644143967331,"gmtModify":1663239746047,"authorId":3577625682381834,"author":{"id":3577625682381834,"idStr":"3577625682381834","authorId":3577625682381834,"name":"CleavonFx","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":183913758,"type":1,"supId":0,"prevId":0,"content":".","text":".","html":"."}],"langContent":"EN"},{"id":117323194,"gmtCreate":1623117879218,"gmtModify":1704196436025,"author":{"id":"3577089953267281","authorId":"3577089953267281","name":"Annalz","avatar":"https://static.tigerbbs.com/ffd285ab6189bb61da4b48c3e149eedc","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3577089953267281","authorIdStr":"3577089953267281"},"htmlText":"Haha","listText":"Haha","text":"Haha","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/117323194","repostId":1113342569,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":117396584,"gmtCreate":1623116020048,"gmtModify":1704196371275,"author":{"id":"3575066301734945","authorId":"3575066301734945","name":"bunny9078","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3575066301734945","authorIdStr":"3575066301734945"},"htmlText":"Ooo","listText":"Ooo","text":"Ooo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/117396584","repostId":1113342569,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4626301,"gmtCreate":1623116879063,"gmtModify":1635332755472,"authorId":3581772577454351,"author":{"id":3581772577454351,"idStr":"3581772577454351","authorId":3581772577454351,"name":"TCRaN","avatar":"https://static.tigerbbs.com/60cd232b0f9d8e680c9d686852e39bcb","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":117396584,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"}],"langContent":"EN"},{"id":117393591,"gmtCreate":1623115895913,"gmtModify":1704196367351,"author":{"id":"3568071651427696","authorId":"3568071651427696","name":"Pigmonkey","avatar":"https://static.tigerbbs.com/3402225c0172781df7553e20722ebad7","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3568071651427696","authorIdStr":"3568071651427696"},"htmlText":"Comment pls","listText":"Comment pls","text":"Comment pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/117393591","repostId":1113342569,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4630352,"gmtCreate":1623138288470,"gmtModify":1663228190248,"authorId":3573721781255613,"author":{"id":3573721781255613,"idStr":"3573721781255613","authorId":3573721781255613,"name":"szueyann","avatar":"https://static.tigerbbs.com/cba9c6b1e785a9cf7301a7e6a2ff2354","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":117393591,"type":1,"supId":0,"prevId":0,"content":"ok. done","text":"ok. done","html":"ok. done"},{"id":4625952,"gmtCreate":1623116001116,"gmtModify":1663228163827,"authorId":3577092942653022,"author":{"id":3577092942653022,"idStr":"3577092942653022","authorId":3577092942653022,"name":"XNOP593","avatar":"https://static.tigerbbs.com/732877c9630f22cc8eb6bebac5e10f6d","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":117393591,"type":1,"supId":0,"prevId":0,"content":"Response back","text":"Response back","html":"Response back"}],"langContent":"EN"},{"id":117390424,"gmtCreate":1623115805068,"gmtModify":1704196364569,"author":{"id":"3571697757751706","authorId":"3571697757751706","name":"JamesPang","avatar":"https://community-static.tradeup.com/news/936d6e2f7f57e8860a9bdfab91b7f40e","vip":1,"hat":"https://static.tigerbbs.com/0a8758340a08196056f8bc1e54805193","crmLevel":4,"crmLevelSwitch":0,"idStr":"3571697757751706","authorIdStr":"3571697757751706"},"htmlText":"Like and comment","listText":"Like and comment","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/117390424","repostId":1113342569,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4625910,"gmtCreate":1623115850509,"gmtModify":1663228167545,"authorId":3571199921041604,"author":{"id":3571199921041604,"idStr":"3571199921041604","authorId":3571199921041604,"name":"ShenSiang","avatar":"https://static.tigerbbs.com/1f4f1e93da6d6ca9664728e4cfc578bb","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":117390424,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"},{"id":4625927,"gmtCreate":1623115905745,"gmtModify":1635332795008,"authorId":3568071651427696,"author":{"id":3568071651427696,"idStr":"3568071651427696","authorId":3568071651427696,"name":"Pigmonkey","avatar":"https://static.tigerbbs.com/3402225c0172781df7553e20722ebad7","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":117390424,"type":1,"supId":4625910,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"}],"langContent":"EN"},{"id":117304241,"gmtCreate":1623115756683,"gmtModify":1704196361622,"author":{"id":"3573721781255613","authorId":"3573721781255613","name":"szueyann","avatar":"https://static.tigerbbs.com/cba9c6b1e785a9cf7301a7e6a2ff2354","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3573721781255613","authorIdStr":"3573721781255613"},"htmlText":"Please like and comment. Thanks","listText":"Please like and comment. Thanks","text":"Please like and comment. Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/117304241","repostId":1113342569,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4630366,"gmtCreate":1623138321244,"gmtModify":1663228186347,"authorId":3573721781255613,"author":{"id":3573721781255613,"idStr":"3573721781255613","authorId":3573721781255613,"name":"szueyann","avatar":"https://static.tigerbbs.com/cba9c6b1e785a9cf7301a7e6a2ff2354","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":117304241,"type":1,"supId":4625896,"prevId":0,"content":"thanks","text":"thanks","html":"thanks"},{"id":4625896,"gmtCreate":1623115802568,"gmtModify":1663228162955,"authorId":3557792824461548,"author":{"id":3557792824461548,"idStr":"3557792824461548","authorId":3557792824461548,"name":"Monies","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":117304241,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"}],"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":66,"commentSize":12,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1113342569"}